18F-FDG PET/CT Identified Rectal Malignancy Earlier Than 68Ga-FAPI PET/CT
A 69-year-old man with esophageal cancer underwent dual-tracer PET/CT using 18 F-FDG and 68 Ga-FAPI during his treatment. At baseline, neither scan showed abnormal uptake in the rectum. Three months later, an interim 18 F-FDG PET/CT revealed focal uptake in the rectum, while the 68 Ga-FAPI PET/CT showed no abnormal findings. Seventeen months later, he received a third dual-tracer PET/CT for surveillance. Both 18 F-FDG and 68 Ga-FAPI PET/CT detected abnormal activity in the same area of the rectum . The lesion was later confirmed as adenocarcinoma by histopathology after surgery. Our case demonstrated the 18 F-FDG PET/CT could identify the rectal malignancy before 68 Ga-FAPI PET/CT.
Authors
- Hui Wang (ORCID: https://orcid.org/0000-0003-1494-6668)
- Minggang Su (ORCID: https://orcid.org/0000-0003-0686-0805)
Institutions
- Sichuan University (CN)
- West China Hospital of Sichuan University (CN)
- National Health Insurance Fund (RS)
Publication Details
- Journal
- Clinical Nuclear Medicine
- Published
- 2025-03-05
- DOI
- https://doi.org/10.1097/rlu.0000000000005800
- Citations
- 1
- Primary Topic
- Peptidase Inhibition and Analysis
- Type
- article
- Field-Weighted Citation Impact
- 1.05